Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 13 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days agoVaccines and Related Biological Products Advisory Committee recommended the development of an...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 21 hours agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 5 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 5 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 1 day agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
FDA advises Covid vaccine makers to target KP.2 for fall shots
NBC News via Yahoo News· 5 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...